Business Context and Reporting Period
Company: Primedex Health Systems, Inc. (Note: Metadata lists Radnet, Inc., but the filing is for Primedex Health Systems, Inc., which operates Radnet facilities).
Reporting Period: Quarter ended January 31, 2001.
Business Overview: The Company provides diagnostic imaging services in California through its subsidiaries, including Radnet Management, Inc. and Diagnostic Imaging Services, Inc. (DIS). The Company operates imaging centers offering MRI, CT, and PET scan services.
Key Financial Metrics
| Metric | Q1 2001 (3 Months) | Q1 2000 (3 Months) |
|---|---|---|
| Net Revenue | $24,110,010 | $19,983,742 |
| Income from Operations | $4,212,555 | $2,619,233 |
| Net Income (Loss) | $922,582 | $(197,625) |
| EPS (Basic & Diluted) | $0.02 | $(0.01) |
| Cash from Operating Activities | $1,577,692 | $2,306,199 |
| Cash and Equivalents (End of Period) | $21,309 | $37,880 |
| Working Capital Deficit | $(33,945,460) | Not explicitly stated for Q1 2000 |
| Total Debt (Current + Long Term) | $144,713,789 | Not explicitly stated for Q1 2000 |
Note: Total Debt calculated as sum of Current portion of notes/leases, Note payable to related party, Subordinated debentures, and Long-term notes/leases.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased approximately 21% year-over-year, driven by the addition of five new sites (San Francisco, Emeryville, Tarzana, Chino, San Gabriel Valley) and equipment upgrades.
- Profitability: The Company returned to profitability with a net income of $922,582, compared to a net loss of $197,625 in the prior year. Operating income increased by approximately 61%.
- Expense Management: Operating expenses increased 15%, primarily due to new facility costs and higher maintenance fees. However, the provision for bad debts decreased significantly from $987,524 to $668,325.
- Debt Restructuring: Significant debt restructuring occurred, including the conversion of a $5.5 million note into redeemable preferred stock and the renegotiation of GE notes to extend payment terms.
Outlook, Risks, and Unusual Items
Going Concern Warning
The independent accountant's report and Note 10 explicitly state there is substantial doubt about the Company's ability to continue as a going concern. This is due to a stockholders' deficit of $59.9 million and a working capital deficit of $33.9 million.
Management Plans
- Opening new centers (e.g., Tarzana MRI/CT/PET center expected June 2001).
- Negotiating new capitation contracts (e.g., Riverside facility saw 140% revenue increase in March 2001).
- Consolidating underperforming facilities (e.g., Sacramento consolidation).
- Continued debt renegotiation to extend terms and reduce monthly payments.
Subsequent Events
- Asset Sale: On March 1, 2001, the Company sold a radiation therapy center in Temecula for $4 million, expecting a gain of approximately $3.5 million.
- Debt Repurchase: On March 14, 2001, the Company repurchased $18,000 face value of subordinated debentures for $9,000, recognizing a $9,000 gain.
Investor Verification Checklist
- Liquidity Status: Verify the sufficiency of cash flow given the $33.9 million working capital deficit and minimal cash on hand ($21,309).
- Debt Covenants: Review the terms of the two primary lines of credit (Coast Business Credit and DVI Business Credit) for potential defaults or renewal risks.
- Going Concern Resolution: Assess the feasibility of management's plans to eliminate the stockholders' deficit and achieve sustained profitability.
- Subsequent Event Impact: Confirm the closing of the Temecula center sale and the recognition of the $3.5 million gain in the next reporting period.
- Related Party Transactions: Review the $2.55 million note payable to a related party and the $75,000 advance to an officer for terms and repayment schedules.